VREOF (Vireo Growth) 3-Year Revenue Growth Rate : 11.70% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Vireo Growth 3-Year Revenue Growth Rate?

Vireo Growth's Revenue per Share for the three months ended in Dec. 2024 was $0.11.

During the past 12 months, Vireo Growth's average Revenue per Share Growth Rate was -10.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Vireo Growth was 17.50% per year. The lowest was 10.60% per year. And the median was 11.70% per year.

Competitive Comparison of Vireo Growth's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vireo Growth's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Vireo Growth's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Vireo Growth 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Vireo Growth (OTCPK:VREOF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Vireo Growth 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Vireo Growth's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Vireo Growth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vireo Growth Inc (OTCPK:VREOF) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

0ZF:Germany VREO:Canada

Address

207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402

Website

https://www.vireogrowth.com

Vireo Growth Inc is a cannabis company whose mission is to provide safe access, quality products, and value to its customers while supporting its local communities through active participation and restorative justice programs. The company's operating results in one business segment: the cultivation, production, and sale of cannabis.

Executives

Chicago Atlantic Credit Opportunities, Llc	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Manager, Llc	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Gp Holdings, Llc	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Group, Lp	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Group Gp, Llc	10 percent owner	420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Advisers, Llc	10 percent owner	420 NORTH WABASH AVENUE, SUITE 500, CHICAGO IL 60611
Joshua Rosen	director	207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Victor E. Mancebo	director	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Christian Gonzales Ocasio	officer: Chief Operating Officer	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Amber Holly Shimpa	director, officer: Chief Administrative Officer	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Patrick Peters	officer: EVP of Retail	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
J Michael Schroeder	officer: General Counsel & CCO	3680 VICTORA STREET N, SHOREVIEW MN 55126
John Andrew Heller	officer: Chief Financial Officer	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Ross Michael Hussey	director	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Judd Theodore Nordquist	director	C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402